{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:33:12Z","timestamp":1784010792913,"version":"3.55.0"},"reference-count":38,"publisher":"BMJ","funder":[{"name":"Queensland Children\u2019s Hospital Foundation","award":["50273"],"award-info":[{"award-number":["50273"]}]},{"DOI":"10.13039\/501100010443","name":"RACP Foundation","doi-asserted-by":"publisher","award":["2022REF00054"],"award-info":[{"award-number":["2022REF00054"]}],"id":[{"id":"10.13039\/501100010443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1019834"],"award-info":[{"award-number":["1019834"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1040830"],"award-info":[{"award-number":["1040830"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1131932"],"award-info":[{"award-number":["1131932"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2025379"],"award-info":[{"award-number":["2025379"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2041755"],"award-info":[{"award-number":["2041755"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gold Coast Hospital Clinical Research Fellowship","award":["2023-002"],"award-info":[{"award-number":["2023-002"]}]},{"name":"Queensland Advancing Research Fellowship","award":["CRF3-2021-no number"],"award-info":[{"award-number":["CRF3-2021-no number"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,5,18]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In most chronic airway diseases, identifying phenotypes has advanced clinical practice and research. However, no such phenotypes exist for paediatric bronchiectasis. We therefore sought to develop robust paediatric bronchiectasis phenotypes and to investigate whether they were associated with relevant clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Latent class analysis was independently applied to two study cohorts of children with bronchiectasis. Data from 158 children from one study (BEST, development cohort) were used to identify phenotypes and their associations with relevant clinical outcomes. A cohort of 198 children from a second study (BAMP) was used to validate these phenotypes and compare findings for consistency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A three-class model was the best fit in the BEST cohort. Based on clinical characteristics, we labelled the phenotypes as \u2018Baseline-Well\u2019, \u2018Wheeze-Dyspnoea Predominant\u2019 and \u2018Daily Wet-Cough Predominant\u2019. These phenotypes were validated in the BAMP cohort. In both development and validation cohorts, the \u2018Daily Wet-Cough Predominant\u2019 phenotype was associated with higher numbers of bronchiectatic lobes (OR 1.61, 95% CI 0.61 to 4.27; and 3.06, 95%\u2009CI 1.30 to 7.21 for BEST and BAMP cohorts, respectively) and more bronchiectasis-related hospitalisations ever at enrolment (incidence rate ratio (IRR) 4.33, 95%\u2009CI 1.94 to 9.66; and 2.96, 95%\u2009CI 1.07 to 8.20, respectively) and also within 2\u2009years of enrolment (IRR 2.68, 95%\u2009CI 1.24 to 5.8; and 1.54, 95%\u2009CI 0.72 to 3.28, respectively) than the reference phenotype, although the strengths of evidential support differed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified and validated three novel paediatric bronchiectasis phenotypes, and linked them to distinct clinical outcomes. These phenotypes might enable targeted interventions and improve participant selection for clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2025-224359","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:20:27Z","timestamp":1780939227000},"page":"thorax-2025-224359","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Paediatric bronchiectasis phenotypes and their association with clinical outcomes: development and validation in two prospective clinical cohorts"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7533-2315","authenticated-orcid":false,"given":"Vikas","family":"Goyal","sequence":"first","affiliation":[{"name":"Australian Centre for Health Services Innovation and School of Medicine, Queensland University of Technology, Brisbane, Queensland, Australia"},{"name":"Respiratory and Sleep, Queensland Children\u2019s Hospital, South Brisbane, Queensland, Australia"},{"name":"Paediatrics, Gold Coast University Hospital, Southport, Queensland, Australia"},{"name":"Paediatrics, Griffith University School of Medicine and Dentistry, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Vicendese","sequence":"additional","affiliation":[{"name":"Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne School of Population and Global Health, Carlton, Victoria, Australia"},{"name":"Mathematics and Statistics, La Trobe University School of Computing Engineering and Mathematical Sciences, Melbourne, Victoria, Australia"},{"name":"Allergy and Immunology Murdoch Children's Research Institute, The Royal Children\u2019s Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Grimwood","sequence":"additional","affiliation":[{"name":"Paediatrics, Griffith University School of Medicine and Dentistry, Gold Coast, Queensland, Australia"},{"name":"Child and Maternal Health Division, NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Yerkovich","sequence":"additional","affiliation":[{"name":"Australian Centre for Health Services Innovation and School of Medicine, Queensland University of Technology, Brisbane, Queensland, Australia"},{"name":"Child and Maternal Health Division, NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6063-1937","authenticated-orcid":false,"given":"Shyamali","family":"Dharmage","sequence":"additional","affiliation":[{"name":"Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne School of Population and Global Health, Carlton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1331-3706","authenticated-orcid":false,"given":"Anne B","family":"Chang","sequence":"additional","affiliation":[{"name":"Australian Centre for Health Services Innovation and School of Medicine, Queensland University of Technology, Brisbane, Queensland, Australia"},{"name":"Respiratory and Sleep, Queensland Children\u2019s Hospital, South Brisbane, Queensland, Australia"},{"name":"Child and Maternal Health Division, NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2026060810202026000_thorax-2025-224359v1.1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccm.2021.11.006","article-title":"Bronchiectasis in Childhood","volume":"43","author":"Goyal","year":"2022","journal-title":"Clin Chest Med"},{"key":"2026060810202026000_thorax-2025-224359v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31554-X"},{"key":"2026060810202026000_thorax-2025-224359v1.3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00300-2022","article-title":"European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials","volume":"60","author":"Chang","year":"2022","journal-title":"Eur Respir J"},{"key":"2026060810202026000_thorax-2025-224359v1.4","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0085-2024","article-title":"Exacerbations of bronchiectasis","volume":"33","author":"De Angelis","year":"2024","journal-title":"Eur Respir Rev"},{"key":"2026060810202026000_thorax-2025-224359v1.5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S2213-2600(18)30456-9","article-title":"A new dawn: inhaled antibiotics for patients with bronchiectasis","volume":"7","author":"Grimwood","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026060810202026000_thorax-2025-224359v1.6","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00013-2018","article-title":"Understanding asthma phenotypes: the World Asthma Phenotypes (WASP) international collaboration","volume":"4","author":"Pembrey","year":"2018","journal-title":"ERJ Open Res"},{"key":"2026060810202026000_thorax-2025-224359v1.7","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219301"},{"key":"2026060810202026000_thorax-2025-224359v1.8","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8712-1"},{"key":"2026060810202026000_thorax-2025-224359v1.9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: the E-FACED score","volume":"12","author":"Martinez-Garcia","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026060810202026000_thorax-2025-224359v1.10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2213-2600(25)00089-X","article-title":"First results from the international paediatric bronchiectasis registry (Child-BEAR-Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross-sectional study","volume":"13","author":"Garriga-Grimau","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026060810202026000_thorax-2025-224359v1.11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/resp.14479","article-title":"Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand","volume":"28","author":"Chang","year":"2023","journal-title":"Respirology"},{"key":"2026060810202026000_thorax-2025-224359v1.12","doi-asserted-by":"crossref","first-page":"106627","DOI":"10.1016\/j.rmed.2021.106627","article-title":"Factors associated with \u201cFrequent Exacerbator\u201d phenotype in children with bronchiectasis: The first report on children from the Australian Bronchiectasis Registry","volume":"188","author":"Kapur","year":"2021","journal-title":"Respir Med"},{"key":"2026060810202026000_thorax-2025-224359v1.13","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.chest.2023.07.002","article-title":"Phenotypic Features of Pediatric Bronchiectasis Exacerbations Associated With Symptom Resolution After 14 Days of Oral Antibiotic Treatment","volume":"164","author":"Goyal","year":"2023","journal-title":"Chest"},{"key":"2026060810202026000_thorax-2025-224359v1.14","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00122-2021","article-title":"Clinical and research priorities for children and young people with bronchiectasis: an international roadmap","volume":"7","author":"Chang","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026060810202026000_thorax-2025-224359v1.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200711-1754OC"},{"key":"2026060810202026000_thorax-2025-224359v1.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.02344.x"},{"key":"2026060810202026000_thorax-2025-224359v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2022.10.011"},{"key":"2026060810202026000_thorax-2025-224359v1.18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S2213-2600(19)30254-1","article-title":"Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial","volume":"7","author":"Goyal","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026060810202026000_thorax-2025-224359v1.19","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(18)31723-9","article-title":"Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial","volume":"392","author":"Goyal","year":"2018","journal-title":"Lancet"},{"key":"2026060810202026000_thorax-2025-224359v1.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049007","article-title":"Utility of a personalised Bronchiectasis Action Management Plan (BAMP) for children with bronchiectasis: protocol for a multicentre, double-blind parallel, superiority randomised controlled trial","volume":"11","author":"Marchant","year":"2021","journal-title":"BMJ Open"},{"key":"2026060810202026000_thorax-2025-224359v1.21","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-13-156","article-title":"Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial","volume":"13","author":"Chang","year":"2012","journal-title":"Trials"},{"key":"2026060810202026000_thorax-2025-224359v1.22","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-14-53","article-title":"Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial","volume":"14","author":"Chang","year":"2013","journal-title":"Trials"},{"key":"2026060810202026000_thorax-2025-224359v1.23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.chest.2025.08.021","article-title":"Pediatric Bronchiectasis Action Management Plan to Improve Clinical Outcomes: A Randomized Controlled Trial","volume":"168","author":"Schutz","year":"2025","journal-title":"Chest"},{"key":"2026060810202026000_thorax-2025-224359v1.24","unstructured":"Lanza CL . Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences. 2010."},{"key":"2026060810202026000_thorax-2025-224359v1.25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10705510701575396","article-title":"Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study","volume":"14","author":"Nylund","year":"2007","journal-title":"Structural Equation Modeling: A Multidisciplinary Journal"},{"key":"2026060810202026000_thorax-2025-224359v1.26","doi-asserted-by":"publisher","DOI":"10.1080\/10705511.2013.824781"},{"key":"2026060810202026000_thorax-2025-224359v1.27","doi-asserted-by":"publisher","DOI":"10.1177\/0095798420930932"},{"key":"2026060810202026000_thorax-2025-224359v1.28","unstructured":"R Foundation for Statistical Computing V, Austria . R core team (2021). R: a language and environment for statistical computing. Vienna, Austria, 2022. Available: https:\/\/www.R-project.org"},{"key":"2026060810202026000_thorax-2025-224359v1.29","doi-asserted-by":"publisher","DOI":"10.18637\/JSS.V042.I08"},{"key":"2026060810202026000_thorax-2025-224359v1.30","first-page":"1","volume-title":"Create Elegant Data Visualisations Using the Grammar of Graphics Version","volume":"2","author":"Wickham","year":"2016"},{"key":"2026060810202026000_thorax-2025-224359v1.31","unstructured":"StataCorp . Stata statistical software: release 16. College Station, TX StataCorp LLC; 2019."},{"key":"2026060810202026000_thorax-2025-224359v1.32","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2014.00920","article-title":"Is adding more indicators to a latent class analysis beneficial or detrimental? Results of a Monte-Carlo study","volume":"5","author":"Wurpts","year":"2014","journal-title":"Front Psychol"},{"key":"2026060810202026000_thorax-2025-224359v1.33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/cea.12478","article-title":"Differential factors associated with challenge-proven food allergy phenotypes in a population cohort of infants: a latent class analysis","volume":"45","author":"Peters","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"2026060810202026000_thorax-2025-224359v1.34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.201807-1355OC","article-title":"Distinct \u201cImmunoallertypes\u201d of Disease and High Frequencies of Sensitization in Non-Cystic Fibrosis Bronchiectasis","volume":"199","author":"Mac Aog\u00e1in","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060810202026000_thorax-2025-224359v1.35","article-title":"Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis","volume":"2014","author":"Goyal","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026060810202026000_thorax-2025-224359v1.36","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02990-2020","article-title":"European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis","volume":"58","author":"Chang","year":"2021","journal-title":"Eur Respir J"},{"key":"2026060810202026000_thorax-2025-224359v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2023.03.004"},{"key":"2026060810202026000_thorax-2025-224359v1.38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/17476348.2023.2205125","article-title":"The role of precision medicine in bronchiectasis: emerging data and clinical implications","volume":"17","author":"Oscullo","year":"2023","journal-title":"Expert Rev Respir Med"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2025-224359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:20:32Z","timestamp":1780939232000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2025-224359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":38,"alternative-id":["10.1136\/thorax-2025-224359"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2025-224359","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}